PSG RxWire
Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
DRUGS APPROVED

FDA Approves Entyvio (vedolizumab) to treat Ulcerative Colitis and Crohn's Disease

FDA approved the lowest number of new drugs in 14 years in Q1

FDA unveils new biosimilars guidance

FDA Asks: What Would Happen if Drugs Advertised Their Price?

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose


PBMI
SUMMARY OF TOP ARTICLES - MAY 22, 2014

If you missed it – you can now view this week’s recorded Artemetrx Webinar
Artemetrx - May 21, 2014
Encore Session - Understanding Differences in Specialty Drug Pricing across the Pharmacy and Medical Benefit

Physicians Doubt Possibility of Fully Connected U.S. Health System
iHealthBeat - May 20, 2014
A majority of physicians are interested in implementing or expanding mobile health technologies, but few think health systems can become completely connected in the near future, according to a recent survey from MedData Group, Healthcare IT News reports

Seven Trends For Specialty Pharmacy’s Future: Reflections on Armada 2014
Drug Channels - May 15, 2014
Presented earlier this month at the Armada Healthcare Specialty Pharmacy Summit & Expo, in Las Vegas, Adam J. Fein, Ph.D. summarizes the top seven trends for specialty pharmacy's future.

Drugs in the Pipeline
Monthly Prescribing Reference (MPR) - May 21, 2014
Updates on new drug therapies in development.

Health Centers Hurt In States That Skipped Medicaid Expansion
NPR - May 9, 2014
More than 1 million patients who use federally funded community health centers will remain uninsured because they live in 24 states that chose not to expand Medicaid under the Affordable Care Act, according to a study released Friday by researchers at George Washington University.

Pharma's war on a drug program would hurt city's underserved
Crain's Chicago Business - April 15, 2014
While millions of Americans have benefited from the [340B drug discount program], it has powerful detractors in Washington. The Pharmaceutical Research and Manufacturers of America association and its allies want to place burdensome restrictions on the program, and some would like it repealed altogether even though the drug industry makes an estimated $7.2 billion per year from sales to 340B hospitals and related providers.

Thousands of Toddlers Are Medicated for A.D.H.D., Report Finds, Raising Worries
New York Times - May 16, 2014
More than 10,000 American toddlers 2 or 3 years old are being medicated for attention deficit hyperactivity disorder outside established pediatric guidelines, according to data presented on Friday by an official at the Centers for Disease Control and Prevention.

Biosimilars: 11 Drugs to Watch
Genetic Engineering & Biotechnology News (GEN) - May 19, 2014
If imitation is the sincerest form of flattery, these innovator drugs should be blushing.

Preventing Alzheimer's disease — with an antidepressant
Los Angeles Times - May 14, 2014
Citalopram, an antidepressant better known by its commercial name Celexa, has a remarkable side effect, a new study has found: In both mice bred to develop Alzheimer's disease and in healthy human volunteers, the selective serotonin reuptake inhibitor, or SSRI, drives down the production of a protein called beta-amyloid, which in the brains of those with Alzheimer's clumps together in sticky plaques and is thought to short-circuit the brain's wiring.

New Drug May Help Lower 'Bad' Cholesterol Beyond Statins
HealthDay News - May 13, 2014
Injectable therapy shows promise in global trial but more study needed, researchers say.

Prescription Drug Use Continues to Climb in U.S.
Drugs.com - May 14, 2014
Prescription drugs are playing an increasingly larger role in U.S. life, with nearly half of all Americans taking one or more medications.

Docs will need to enroll in Medicare if they want to prescribe Part D drugs
Modern Healthcare - May 19, 2014
Doctors and other medical professionals will be required to enroll in the Medicare program to prescribe drugs that are paid for by the federal healthcare program, under a rule finalized Monday by the CMS.

Drug benefit program offers needed assistance to many of the region's patients
TriCities.com - May 21, 2014
Dr. Sue Prill, a medical oncologist with Wellmont Medical Associates, provides commentary on the 340B drug purchasing program and its success at Wellmont Health System.


Contact,

Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com

PSGNewsletter@PSGConsults.com
www.PSGConsults.com